Cardiovascular Treatment Equipment (Global Market)

Medical Equipment (Global Market)

Main Article: Medical Equipment (Global Market)

Cardiovascular Ultrasound Equipment (Global Market)

Main Article: Cardiovascular Ultrasound Equipment (Global Market)

2020: Cardiovascular Disease Treatment and Diagnosis Equipment Market Size Reaches $53 Billion

The volume of the global market for equipment used in the treatment and diagnosis of cardiovascular diseases at the end of 2020 turned out to be $53 billion, slightly (by 0.3%) reduced compared to the previous year. Such data in August 2021 were released by Evaluate analysts specializing in health research.

The leader of the market in question was Medtronic, which in 2020 recorded a 20.4 percent share in the asset, which is 0.7 percentage points more than a year earlier. Second place went to Abbott Laboratories, which accounted for 14.6% of sales of equipment for the treatment and diagnosis of heart and vascular diseases. Compared to 2019, Abbott's share decreased by 2 percentage points.

The share of Boston Scientific fell by 1.1 percentage points, which in 2020 amounted to 11.1%. Next is Edwards Lifesciences, which controlled 8.2% of the market, which roughly corresponds to the result of a year ago. The top five was closed by Johnson & Johnson, whose share on an annualized basis increased by 0.1 percentage points, to 5.7%.

In total, the top 5 largest manufacturers of equipment for the treatment of cardiovascular diseases in 2020 occupied 60% of the market.

The market size for equipment for the treatment and diagnosis of cardiovascular diseases in 2020 reached $53 billion

This market in 2020 showed a decline due to the COVID-19 coronavirus pandemic, which led to the fact that a significant part of the resources of world health care was thrown into the fight against this infection. Under these conditions, heart and vascular operations, as well as diagnostic examinations, were delayed, and hospitals and clinics restrained the costs of the appropriate technique.

However, analysts are confident that this decline was temporary, and further sales of equipment for the treatment of cardiovascular diseases will grow, as more people around the world face stroke, cardiomyopathy, etc.

According to WHO data for 2020, coronary heart disease accounts for 16% of all deaths in the world. Since 2000, the largest increase in deaths has been attributed to coronary heart disease, increasing by more than 2 million to 8.9 million deaths. This high prevalence leads to enormous economic pressure on each country's health systems.

Cardiovascular Disease Treatment and Diagnosis Equipment Market Leaders

Moreover, the technologies used in the development of cardiac devices have improved significantly over the past decade, and the functionality of such devices has expanded. Thanks to this, more and more patients receive timely treatment and diagnoses. Artificial intelligence is one such advance with a significant positive impact on cardiology, thanks to improved diagnostic capabilities for some heart diseases.

The market in question is divided into cardiac diagnostic devices (electrocardiographs and remote cardiac monitoring machines) and surgical (used in operations). The latter segment is more consolidated and highly competitive. Large companies are leading here, but local manufacturers are trying to compete with giants. To counter small players, it is not uncommon for large manufacturers to buy them.

The largest market for such equipment remains the United States due to the high prevalence of cardiovascular diseases, the widespread use of minimally invasive procedures, government subsidies, an increase in the number of elderly people and high demand for devices for continuous monitoring of the health of "cores" at home.^[1]

Notes